ArticleInfection and drug resistance2020

Favipiravir Use in COVID-19: Analysis of Suspected Adverse Drug Events Reported in the WHO Database.

Rimple Jeet Kaur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.